|
|
|
Volumn 26, Issue 5 SUPPL. 16, 1999, Pages 17-23
|
|
Docetaxel in the treatment of non-small cell lung cancer: Review of single-agent trials
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
DOCETAXEL;
GEMCITABINE;
NAVELBINE;
PLATINUM;
ADULT;
ARTICLE;
ASTHENIA;
BONE MARROW SUPPRESSION;
CANCER SURVIVAL;
CLINICAL TRIAL;
FEMALE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PHASE 3 CLINICAL TRIAL;
PHASE 4 CLINICAL TRIAL;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SURVIVAL TIME;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
HUMANS;
LUNG NEOPLASMS;
PACLITAXEL;
RADIATION-SENSITIZING AGENTS;
RADIOTHERAPY, ADJUVANT;
TAXOIDS;
|
|
EID: 0032740752
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (13)
|
|
References (45)
|
